NCT04101188 Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans
| NCT ID | NCT04101188 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Delaware |
| Condition | Cardiovascular Risk Factor |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2020-01-16 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2020-01-16 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Americans continue to consume high amounts of sodium. Potassium is notable for its blood pressure lowering effects but less is known regarding its effect on the vasculature. This investigation seeks to determine the role of dietary potassium on the vasculature in the presence of a high sodium diet in salt-resistant adults.
Eligibility Criteria
Inclusion Criteria: * healthy * normal blood pressure * normal resting ECG Exclusion Criteria: * hypertension * history of heart disease * diabetes * kidney disease * obese (BMI ≥30) * significant weight changes in the last 6 months * use of tobacco products * pregnant * on a special diet (gluten free; vegan) * take any medications for the above conditions * endurance trained athletes
Contact & Investigator
Shannon L Lennon, PhD
PRINCIPAL INVESTIGATOR
University of Delaware
Frequently Asked Questions
Who can join the NCT04101188 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Cardiovascular Risk Factor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04101188 currently recruiting?
Yes, NCT04101188 is actively recruiting participants. Contact the research team at slennon@udel.edu for enrollment information.
Where is the NCT04101188 trial being conducted?
This trial is being conducted at Newark, United States.
Who is sponsoring the NCT04101188 clinical trial?
NCT04101188 is sponsored by University of Delaware. The principal investigator is Shannon L Lennon, PhD at University of Delaware. The trial plans to enroll 90 participants.